Clinical Trials List
2021-05-18 - 2027-04-09
Phase III
Recruiting7
ICD-10G30.0
Alzheimer's disease with early onset
ICD-10G30.1
Alzheimer's disease with late onset
ICD-10G30.8
Other Alzheimer's disease
ICD-10G30.9
Alzheimer's disease, unspecified
ICD-9331.0
Alzheimer's disease
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Chau-Chung Wu 未分科
- SHIN-JOE YEH 無
- SUNG-CHUN TANG 無
- MEI-FANG CHENG 無
- YA-FANG CHEN 無
- 程郁文 無
- CHIH-HAO CHEN 無
- LI-KAI TSAI 無
- 蔡欣熹 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Han-Lin Chiang 無
- 林詠萱 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 廖洺鋒 無
- Kun-Ju Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 許世偉 無
- 黃啟維 無
- 李蓉蓉 無
- 黃淑華 無
- Hong jie Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Pin Hong 無
- 張維紘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
1840 participants
